Authors


Carly Szabo, Assistant Editor

Latest:

'Tweezer' Molecule May Improve Infectious Disease Prevention

Research may lead to gel that prevents transmission of HIV, hepatitis C and the Ebola virus.


Kimberly A. Bergstrom, PharmD

Latest:

Management of Unresectable Locoregionally Advanced and Metastatic Nonsquamous NSCLC

Efficacy, toxicity, and costs are all important components of formulating an appropriate care pathway for unresectable locoregionally advanced and metastatic NSCLC.



Engy F. Kheir, PharmD

Latest:

Help Manage and Treat Parkinson Disease

Pharmacists play an integral role and can improve patients’ quality of life with proper communication, counseling, and monitoring.


Max M. Sow, MBA

Latest:

E-Prescribing Is Becoming a Standard of Care

E-prescribing adoption has increased dramatically over the past decade. This study provides empirical evidence that utilization among adopters continues to increase, suggesting application “stickiness.”


Saswat K. Kabisatpathy, PharmD

Latest:

Promoting Brain Function Is Key Amid COVID-19 Crisis

Necessary measures taken during the pandemic may exacerbate some underlying factors that can lead to decline.


Amanda Chea, Doctor of Pharmacy Candidate

Latest:

Zooming Through the Pandemic: NSU Virtual AMCP Student Chapter

There are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.


Yin S. Chen, PharmD Candidate

Latest:

OTC Drug Monograph Reform Is on the Horizon

The success of PDUFA raises questions about additional funding to market nonprescription products.


Mike Hennessy Sr, chairman & founder

Latest:

Lung Cancer Treatment Is Continuously Moving Forward

As treatments for lung cancer move forward and patient care services continue to expand, the role of the pharmacist in oncology is critical.


Kenneth C. Jackson II, PharmD, CPE

Latest:

Opioid-Induced Constipation: Considerations for Formulary Decision Makers

This activity reviews the incidence and impact of opioid-induced constipation (OIC), discusses available treatment options, and what factors should be considered during formulary decisions for OIC.


Guido R. Zanni, PhD

Latest:

Acne: More than a Cosmetic Problem

People of all ages can develop acne, but many treatments are available.




Laurie Toich, Associate Editor

Latest:

Precision Medicine Opens New Possibilities to Treat Rheumatoid Arthritis

Genetic sequencing of joint biopsies may identify which patients with rheumatoid arthritis may respond to therapy.


Laurin Dixon, PharmD

Latest:

Emerging Trends in Adherence and Quality Measurement: What the Future Holds

Adherence measurement can help patients achieve better outcomes.


Kevin Copsey

Latest:

The Power of Medication Packaging Automation During COVID-19

In a world increasingly influenced by technology, there is ample opportunity to leverage automation within pharmacies that can not only improve operations, but support patient wellness.



Barbara Sax

Latest:

Supermarkets: Linking Patients, Pharmacists, and Nutrition

Supermarket pharmacies match patient service offerings of chain drug stores and can offer pharmacists a fulfilling, patient-centered career.


Kevin Boesen, PharmD

Latest:

Telephone-Based Cardiovascular Medication Therapy Management in Medicare Part D Enrollees With Diabetes

A telephonic pharmacist-delivered medication therapy management intervention is an effective method for increasing the utilization of guideline-recommended cardiovascular therapies in high-risk Medicare patients with diabetes.


Michael J. Baldzicki, CRCM

Latest:

Specialty Pharmacies: Meeting Payer Needs in an Evolving Market

With the continued growth of the specialty pharmacy market, payers are employing an increasing number of cost and utilization management strategies to ensure proper use of specialty medications. Collaboration between specialty pharmacies and payers is essential.



James G. Stevenson, PharmD, FASHP

Latest:

Challenges with the Introduction of Biosimilars in the US

With the introduction of biosimilars in the United States, there are several significant issues that will challenge those involved in formulary committees and benefit plans, as well as prescribers and pharmacists.


Louis P. Garrison, Jr, PhD

Latest:

Findings Related to Assessing Value for Private US Health Plans

A qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.


Marilyn Bulloch, PharmD, BCPS, FCCM

Latest:

Recognizing the Important Work of Pharmacists as Immunizers During World Immunization Week

Each time a pharmacist immunizes a patient against one of the 27 infections for which a safe and effective vaccine exists, the profession continues to protect communities against diseases that wreaked havoc on generations.


Tadeh Vartanian, PharmD BCGP

Latest:

CBD: Can It Help With Sleep?

A plethora of new research and CBD products have come on the market in a very short time since the Hemp Farming Act of 2018 removed hemp from Schedule I controlled substances.


Marisa Goninen, PharmD

Latest:

The Case for Establishing a Residency Program in Specialty Pharmacy

Pharmacy residency programs offer postgraduate training to launch pharmacists from their formal education into successful careers.


Mindy Houng, MD, FACP

Latest:

Examining New Treatment Strategies Aimed at Stroke Prevention in Patients with Atrial Fibrillation: A Multidisciplinary Discussion

Pharmacists can learn about educating patients on the risk of stroke in atrial fibrillation, monitoring anticoagulation therapy, and participating in disease management opportunities.


Allan Luskin, MD

Latest:

Guidelines for Collaboration Among Physicians, Pharmacists, and Managed Care Organizations to Improve Asthma Outcomes

New ideas, new tools, and new collaborations among managed care, physicians, and pharmacy to optimize value in asthma management.


Colleen Hall, Digital Managing Editor

Latest:

Scott Gottlieb May be Selected to Head FDA

Expedited drug approvals may become a reality if Scott Gottlieb confirmed as head of FDA.


Brian V. Pero

Latest:

Recent Prosecutions on Product Discounts Show Legal Risk Hidden Beneath the Surface

Recent prosecutions have heightened the risk for both market share discounts and discounts in lieu of service fees.